To intubate or not - That is the question: Continuous positive airway pressure versus surfactant and extremely low birthweight infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 91, Issue 6, 2006, Pages

  Finer, N ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; SURFACTANT;

ARTIFICIAL VENTILATION; CARBON DIOXIDE TENSION; CLINICAL TRIAL; DELIVERY ROOM; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; EXTREMELY LOW BIRTH WEIGHT; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MORBIDITY; MORTALITY; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTUBATION, INTRATRACHEAL; PULMONARY SURFACTANTS;

EID: 33750693400     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.099754     Document Type: Review

References (32)

1. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1997;(4):CD000511.
2. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999;(4):CD001456.
3. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510.
4. Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1998;(2):CD001079.
5. Sinn JK, Ward MC, Henderson-Smart DJ. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health 2002;38:597-600.
6. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000;105:1194-201.
7. Serenius F, Ewald U, Farooqi A, et al. Short-term outcome after active perinatal management at 23-25 weeks of gestation. A study from two Swedish perinatal centres. Part 3: neonatal morbidity. Acta Paediatr 2004;93:1090-7.
8. Stoelhorst GMSJ, Rijken M, Martens SE, et al. Changes in neonatology: Comparison of two cohorts of very preterm infants (Gestational age < 32 weeks): The project on preterm and small for gestational age infants 1983 and the Leiden follow-up project on prematurity 1996-1997. Pediatrics 2005;115:396-405.
9. Hintz SR, Kendrick DE, Vohr BR, et al. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics 2005;115:1645-51.
10. Berger TM, Bachmann II. Adams M, et al. Impact of improved survival of very low-birth-weight infants on incidence and severity of bronchopulmonary dysplasia. Biol Neonate 2004;86:124-130.
11. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months-Results from the trial of indomethocin prophylaxis in preterms. J Am Med Assoc 2003;289:1124-9.
12. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-26.
13. Hoekstra RE, Ferrara TB, Couser RJ, et al. Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center. Pediatrics 2004;113:E1-6.
14. Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116:1353-60.
15. Wood NS, Costeloe K, Gibson AT, et al. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child 2005;90:F134-140.
16. Gregory GA, Kitterman JA, Phibbs RH, et al. Treatment of the idiopathic respiratory distress syndrome with CPAP. NEJM 1971;284:1333-40.
17. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002;(2):CD002975.
18. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003;(2):CD000143.
19. Subramaniam P, Henderson-Smart DJ, et al. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2005;(3):CD001243.pub2.
20. Han VKM, Beverley DW, Clarson C, et al. Randomized controlled trial of very early continuous distending pressure in the management of preterm infants. Early Hum Devt 1987;15:21-32.
21. Sandri F, Ancora G, Lanzoni A, et al. Prophylactic nasal continueous positive airway pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Edn 2004;89:F394-8.
22. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
23. Booth C, Premkumar MH, Yannoulis A, et al. Sustainable use of continuous positive airway pressure during the first week after delivery in extremely preterm infants. Arch Dis Childhood, 2006;July 13; (epub ahead of print).
24. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994;331:1051-5.
25. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E241-6.
26. Thomson M, on behalf of the IFDAS investigators. Early nasal continuous positive airways pressure with surfactant for neonates at risk of RDS. Pediatr Res 2002;45:321A.
27. Ammari A, Suri M, Milisavljevic V, et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005;147:341-7.
28. Aly H, Massaro AN, Patel K, et al. Is it safer to intubate premature infants in the delivery room? Pediatrics 2005;115:1660-5.
29. Finer NN, Carlo WA, Duara S, et al. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 2004;114:651-7.
30. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002;(2):CD002975.
31. Davis PG, Lemyre B, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2001;(3):CD003212.
32. Polglase GR, Morley CJ, Crossley KJ, et al. Positive end-expiratory pressure differentially alters pulmonary hemoaynamics and oxygenation in ventilated, very premature lambs. J Appl Physiol 2005;99:1453-61.